Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site
- PMID: 20227411
- DOI: 10.1016/j.febslet.2010.03.016
Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site
Abstract
HIV integrase (IN) is an essential enzyme in HIV replication and an important target for drug design. IN has been shown to interact with a number of cellular and viral proteins during the integration process. Disruption of these important interactions could provide a mechanism for allosteric inhibition of IN. We present the highest resolution crystal structure of the IN core domain to date. We also present a crystal structure of the IN core domain in complex with sucrose which is bound at the dimer interface in a region that has previously been reported to bind integrase inhibitors.
Copyright 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors.J Mol Biol. 2008 Jul 11;380(3):504-19. doi: 10.1016/j.jmb.2008.04.054. Epub 2008 May 1. J Mol Biol. 2008. PMID: 18565342
-
Molecular dynamics simulations of the HIV-1 integrase dimerization interface: guidelines for the design of a novel class of integrase inhibitors.J Chem Inf Model. 2010 Apr 26;50(4):604-14. doi: 10.1021/ci900403s. J Chem Inf Model. 2010. PMID: 20230013
-
Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.Mol Pharmacol. 1996 Oct;50(4):846-55. Mol Pharmacol. 1996. PMID: 8863829
-
HIV type 1 integrase inhibitors: from basic research to clinical implications.AIDS Rev. 2008 Jul-Sep;10(3):172-89. AIDS Rev. 2008. PMID: 18820719 Review.
-
Resistance to HIV-1 integrase inhibitors: A structural perspective.Drug Resist Updat. 2010 Aug-Oct;13(4-5):139-50. doi: 10.1016/j.drup.2010.05.001. Epub 2010 Jun 8. Drug Resist Updat. 2010. PMID: 20570551 Review.
Cited by
-
Small molecule inhibitors of the LEDGF site of human immunodeficiency virus integrase identified by fragment screening and structure based design.PLoS One. 2012;7(7):e40147. doi: 10.1371/journal.pone.0040147. Epub 2012 Jul 10. PLoS One. 2012. PMID: 22808106 Free PMC article.
-
Molecular dynamics approaches estimate the binding energy of HIV-1 integrase inhibitors and correlate with in vitro activity.Antimicrob Agents Chemother. 2012 Jan;56(1):411-9. doi: 10.1128/AAC.05292-11. Epub 2011 Oct 28. Antimicrob Agents Chemother. 2012. PMID: 22037850 Free PMC article.
-
Computational design of a full-length model of HIV-1 integrase: modeling of new inhibitors and comparison of their calculated binding energies with those previously studied.J Mol Model. 2013 Oct;19(10):4349-68. doi: 10.1007/s00894-013-1943-4. Epub 2013 Aug 2. J Mol Model. 2013. PMID: 23907552
-
Structural biology of retroviral DNA integration.Virology. 2011 Mar 15;411(2):194-205. doi: 10.1016/j.virol.2010.12.008. Epub 2011 Jan 8. Virology. 2011. PMID: 21216426 Free PMC article. Review.
-
Basic quinolinonyl diketo acid derivatives as inhibitors of HIV integrase and their activity against RNase H function of reverse transcriptase.J Med Chem. 2014 Apr 24;57(8):3223-34. doi: 10.1021/jm5001503. Epub 2014 Apr 11. J Med Chem. 2014. PMID: 24684270 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases